This site is intended for Healthcare Professionals only.

Boots, PDA agree on 4.5 pc pay rise for multiple’s pharmacists

Date:

Share post:

Boots pharmacists will receive a pay rise of 4.5 per cent as the pharmacy multiple and PDA Union jointly announce this year’s pay settlement.

Following discussions between Boots management services and the PDA Union negotiators, the agreement was reached in relation to this year’s pay claim, effective from 1 November 2022.

The union also announced that those who have already had a pay increase on or since 1 August 2022, where that increase has been less than 4.5 per cent, a ‘top up’ increase will be provided, from 1 November 2022, to ensure that all eligible members of the bargaining unit receive a pay increment of not less than 4.5 per cent in 2022.

Boots and the PDA Union have agreed an increase to the pay of those above the maximum market range by 4 per cent with an additional 0.5 per cent non-consolidated payment.

This year pharmacists who are ineligible for the negotiated increase are:

  • Those who have joined on or since 1 August 2022
  • Those rated as not performing at EOY FY22
  • Trainee Pharmacists

It has also been agreed that “there will be a payment of £100 for pharmacists who work on a non-planned day with less than 48 hours’ notice to cover short notice absence.”

This would be based on £100 for an eight-hour day and pro-rated if the shift length is shorter.

“Boots and the PDAU recognise the current unique market circumstances within the community pharmacy sector relating to the pharmacist workforce and this has been reflected in the agreed package of pay and benefits. Consideration has been given to current price inflation along with the ability of the business to afford and sustain any agreed increases,” said the union.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Haleon to close Maidenhead manufacturing site affecting 435 jobs

Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London Haleon,...

UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition

Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects   British pharmacies and slimming...

MHRA says many online pharmacies are ‘unregulated’,’ illegal’, or ‘fraudulent’

MHRA's latest initiative aims to empower consumers in the fight against online pharmacy frauds The Medicines and Healthcare products...

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...